Long-term efficacy and safety of oxycodone–naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study

Long-term efficacy and safety of oxycodone–naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study

Fabio Guerriero,1,2 Anna Roberto,3 Maria Teresa Greco,4 Carmelo Sgarlata,1 Marco Rollone,2 Oscar Corli3 1Department of Internal Medicine and Medical Therapy, Section of Geriatrics, University of Pavia, 2Department of Geriatrics, Agency for Elderly People of Pavia, Santa Margherita Institute, Pavia,...

Full description

Bibliographic Details
Main Authors: Guerriero F, Roberto A, Greco MT, Sgarlata C, Rollone M, Corli O
Format: Article
Language:English
Published: Dove Medical Press 2016-04-01
Series:Drug Design, Development and Therapy
Subjects:
Oxycodone/Naloxone
geriatric
chronic non-cancer pain
constipation.
Online Access:https://www.dovepress.com/long-term-efficacy-and-safety-of-oxycodonendashnaloxone-prolonged-rele-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/long-term-efficacy-and-safety-of-oxycodonendashnaloxone-prolonged-rele-peer-reviewed-article-DDDT

Similar Items